
P-Cure aims to shift treatment efficacy to a new, unprecedented level – a quantum leap forward in reducing the magnitude of internal organ motion and markedly improving imaging resolution.

P-Cure’s treatment solution is expected to yield improved dose distribution, thereby exposing healthy tissues and organs to significantly less radiation.

With the FDA-cleared Gantry-Less Proton Therapy Solution, patients can be treated in seated or supine positions. It is fully integrated with synchrotron-generated pencil beam scanning to ensure a continuous and precise treatment plan is delivered.

Our solution, comparable in size to single floor linac rooms, is 5 times smaller than a gantry room, and requires 50 percent less shielding.

The P-Cure solution can reduce the capital costs of a proton center by 50 percent, providing wider availability of proton therapy and faster ROI.

Greater comfort, less organ movement, and a potential reduction in collateral radiation to sensitive organs.

“Adaptive therapy approach combined with a proton beam scanning is a quantum leap in our ability to cure cancer patients with radiation.”

“P-Cure’s gantry-less system can significantly reduce the cost of the initial investment required to establish proton therapy services.”

"We expect that imaging lung cancer patients in the upright position will allow us to more precisely target the tumor when we treat it with proton therapy.”

Our Approach
Read More
Request a Demo
Request
Contact Us
Get in touchFounded in 2007, P-Cure is at the forefront of democratizing Proton Therapy, offering the most compact FDA-cleared solution for treating cancer patients. Our comprehensive system enables the planning and treatment of patients with Proton Therapy in both supine and seated positions, tailored to fit linac-like vaults within existing or new radiation therapy centers.
Operating globally with headquarter in Switzerland; production and R&D platforms in the US, Israel, and China; global sales company and global service company in Singapore. We are in the process of setting up a helium ion R&D center in the US and adding a factory and R&D center in Singapore. P-Cure collaborates closely with healthcare providers supporting them in achieving unprecedented return on investment with operating breakeven typically within a year of implementation.
P-Cure is dedicated to ushering in a new era of life-saving technology accessible to all oncology centers and their patients, revolutionizing the cancer treatment landscape worldwide.
Sign up to our Newsletter